| |
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
| 1 |
[GO] |
2024―Jun―10 |
A randomized comparative clinical trial to evaluate the efficacy of Chatushashti Prahari Pippali along with Rehabilitation self-management after COVID-19 related illness in the management of post COVID syndrome |
Manjiri Jayprakash Walinjkar, Mandip Goyal |
| 2 |
[GO] |
2024―Jun―10 |
Ayurveda formulations for prophylaxis against coronavirus disease-2019 infection - A prospective community-based study in identified containment zones of 19 districts across India |
Vipin Sharma, Babita Yadav, Lalita Sharma, Rakesh Rana, Richa Singhal, Arunabh Tripathi, et al. (+46) Shruti Khanduri, Bhagwan Sahay Sharma, Bhogavalli Chandrasekhararao, Narayanam Srikanth, Kartar Singh Dhiman, S. K. Vedi, Suhas Chaudhary, Anil Avhad, Paikrao Sumed, D. S. Rotwar, K.Prameela Devi, Kavita Mansukhbhai Vyas, Alok Kumar Srivastava, Savita Sharma, C. Muralikrishna, Sneha Marlewar, P. L. Bharati, Ranjita Ekka, Deepa Sharma, YR Sanjay Kumar, S.H. Doddamani, Sandip Kumar Ramjivan Baheti, Amin Hetalben, Vimal Tewari, Deepika Tewari, S Asha, Anubha Chandla, Sanjay Kumar Singh, Sangeeta Sangvikar, R Govind Reddy, Bandi Venkateshwarlu, Sujata P Dhoke, Saylee Deshmukh, Girindra Kumar Bora, Achintya Mitra, Shyam Babu Singh, K. S Rohit, Pratibha P. Nair, K. M. Pratap Shankar, P. P. Pradeep kumar, P. S Aswani, Parvathy G. Nair, Rinky Thakur, A.J.V Sai Prasad, Pallavi Mundada, Shyam Kale |
| 3 |
[GO] |
2024―Feb―23 |
Safety and efficacy of COROPROTECT kit as an add-on therapy in the management of mild-to-moderate COVID-19: A randomized, placebo-controlled trial |
Chetan Savaliya, Shridhar Pandya, Kamalesh Thumar, Dheeraj Nagore |
| 4 |
[GO] |
2024―Feb―23 |
Erratum: Balchaturbhadra Churna as a potential medicine for SARS-CoV2 infection in pediatric setting an in silico study |
|
| 5 |
[GO] |
2023―Dez―12 |
Balchaturbhadra Churna as a potential medicine for SARS-CoV2 infection in pediatric setting: An in silico study |
KuldeepR Choudhary, SakethRam Thrigulla, ManoharS Gundeti, Pratyusha Mantena, Shruti Koulgi, Vinod Jani, et al. (+6) VN Mallikarjunachari Uppuladinne, Uddhavesh Sonavane, Rajendra Joshi, GoliPenchala Prasad, RGovind Reddy, Narayanam Srikanth |
| 6 |
[GO] |
2023―Jun―24 |
Medical Marijuana (Cannabis sativa L.) and COVID-19: A note |
Beuy Joob, Viroj Wiwanitkit |
| 7 |
[GO] |
2023―Apr―12 |
An observational study on acceptability, palatability, and safety of Ayurveda immunity booster kit for the prevention of COVID-19 in frontline workers in Jaipur, India |
SarveshKumar Singh, Kshipra Rajoria, Sanjeev Sharma, PawanKumar Godatwar, Suman Sharma, Mita Kotecha, et al. (+4) SarveshKumar Agrawal, RajendraPrasad Sharma, Shobhnath Yadav, Ramkishor Joshi |
| 8 |
[GO] |
2022―Feb―24 |
Efficacy and safety of Guduchighana Vati in asymptomatic and mild-to-moderate cases of coronavirus disease-19: A randomized controlled pilot study |
AmitKumar Rai, Umesh Shukla, Nitin Ujjaliya, Pankaj Gupta, Vivek Khare, Babita Yadav, et al. (+8) Hetalben Amin, Rakesh Rana, Arunabh Tripathi, Shruti Khanduri, BhagwanSahay Sharma, Bhogavalli Chandrasekhararao, Narayanam Srikanth, KartarSingh Dhiman |
| 9 |
[GO] |
2021―Okt―23 |
AYUSH-64 as an add-on to standard care in asymptomatic and mild cases of COVID-19: A randomized controlled trial |
AmitKumar Rai, RGovind Reddy, RajeshVithal Gosavi, Babita Yadav, MadhuriPrashant Holay, Manisha Talekar, et al. (+8) Sophia Jameela, BhagwanSahay Sharma, Shruti Khanduri, Rakesh Rana, Arunabh Tripathi, Bhogavalli Chandrasekhararao, Narayanam Srikanth, KartarS Dhiman |
| 10 |
[GO] |
2021―Jan―13 |
A retrospective analysis of the effect of the intervention of Arogya Kashayam in COVID-19 positive cases in Madhya Pradesh |
Umesh Shukla, Sanjay Srivastava, Pankaj Gupta, Nitin Ujjaliya |
| 11 |
[GO] |
2020―Aug―07 |
Strategies and avenues for COVID-19 - Ayurveda perception |
Mandip Goyal |
|
